FDA Approves Allergan’s Botox for Overactive Bladder

Drug Industry Daily
A A
The FDA has approved a new use for Allergan’s Botox to treat adults with idiopathic overactive bladder who cannot use or do not adequately respond to a class of medications known as anticholinergics.

To View This Article:

Login

Subscribe To Drug Industry Daily